Researchers and leading Universities working with Bioventix antibodies are changing the world
8 April 2024
Abstract Objectives To investigate whether circulating acute-phase brain-derived tau (BD-tau) is associated with functional outcome after ischemic stroke. Methods…
4 April 2024
Abstract Staging amyloid-beta (Aβ) pathophysiology according to the intensity of neurodegeneration could identify individuals at risk for cognitive decline…
23 March 2024
Abstract Blood phosphorylated tau (p-tau) biomarkers, including p-tau217, show high associations with Alzheimer’s disease (AD) neuropathologic change and clinical…
6 October 2023
Abstract INTRODUCTION: Detection of Alzheimer’s disease (AD) pathophysiology among indi- viduals with mild cognitive changes and those experiencing subjective…
19 September 2023
Abstract INTRODUCTION: Rapidly progressive dementias (RPDs) are a group of neurolog- ical disorders characterized by a rapid cognitive decline….
3 July 2023
Abstract IMPORTANCE Blood-based measurements of total tau (T-tau) are commonly used to examine neuronal injury in patients with traumatic…
25 April 2023
Abstract INTRODUCTION: We investigated the effects of matrix type and reagent batch changes on diagnostic performances and longitudinal trajectories…
27 December 2022
Abstract Blood-based biomarkers for amyloid beta and phosphorylated tau show good diagnostic accuracies and agreements with their corresponding CSF…
20 July 2021
Abstract Background: Circulating secretoneurin (SN) concentrations, as measured by established radioimmunoassay (RIA), risk stratify patients with cardiovascular disease. We…